Director of the Imaging Department, Deputy Director of the Interventional Therapy Department, Chief Physician, Professor, and Doctoral Supervisor at Peking University Cancer Hospital. Visiting scholar at MSKCC Cancer Center in the United States from 2010 to 2011. Professional Expertise: Primary liver cancer, cholangiocarcinoma, colorectal cancer liver metastases, gallbladder cancer, colorectal cancer lung metastases, etc. Minimally invasive interventional techniques: arterial chemoembolization, hepatic artery infusion chemotherapy, Y90 radioembolization, microwave ablation, cryoablation, radioactive seed implantation, etc. Social Affiliations: Standing Committee Member of the Tumor Interventional Professional Committee of the Chinese Anti-Cancer Association; Standing Committee Member of the Tumor Minimally Invasive Therapy Professional Committee of the Chinese Anti-Cancer Association; Member of the Tumor Ablation Special Committee of the Interventional Physician Branch of the Chinese Medical Doctor Association; Vice President and Secretary-General of the Interventional Specialist Physician Branch of the Beijing Medical Doctor Association; Standing Committee Member of the Interventional Medicine Branch of the Beijing Medical Association, etc. Representative Achievements: As the principal investigator, led three general projects of the National Natural Science Foundation of China, as well as multiple projects such as the Beijing Natural Science Foundation general project and the Capital Special Project; led the 2021 Clinical Medicine Development Special Key Medical Specialty "Hepatobiliary Tumor Minimally Invasive Interventional Medicine" discipline construction. Served as editor-in-chief, deputy editor-in-chief, and co-author of several monographs: *Interventional Therapy for Primary Liver Cancer*, *Minimally Invasive Tumor Therapy Techniques*, *Clinical Oncology* (graduate textbook), *Emergency Interventional Diagnosis and Treatment*, *Abdominal Oncology*. Drafted and co-drafted multiple domestic expert consensus/guidelines: Chinese Expert Consensus on Modified Percutaneous Hepatic Artery Chemotherapy Port Implantation, Chinese Expert Consensus on Bronchial Artery Infusion and Bronchial Artery Chemoembolization for Lung Cancer, Chinese Expert Consensus on Neoadjuvant and Conversion Therapy for Primary Liver Cancer, Chinese Clinical Practice Guidelines for Transarterial Interventional Therapy of Hepatocellular Carcinoma, Chinese Expert Consensus on the Application of Transarterial Infusion Chemotherapy Drugs. Published multiple SCI papers in journals such as *Radiology*, *Liver Cancer*, *JVIR*, *CVIR*. Awarded the CVIR Outstanding Contribution Award by the European Society of Interventional Radiology in 2014.